LGL Group, Inc. (The) (NYSEAMERICAN:LGL – Get Free Report) was the target of a significant drop in short interest in July. As of July 31st, there was short interest totaling 53,731 shares, a drop of 64.1% from the July 15th total of 149,543 shares. Approximately 1.0% of the company’s stock are sold short. Based on an average trading volume of 4,789 shares, the days-to-cover ratio is currently 11.2 days.
Wall Street Analyst Weigh In
Separately, Zacks Research raised shares of LGL Group to a “hold” rating in a research report on Thursday, May 7th. One equities research analyst has rated the stock with a Hold rating, According to MarketBeat.com, the stock presently has a consensus rating of “Hold”.
Check Out Our Latest Stock Analysis on LGL
Institutional Investors Weigh In On LGL Group
LGL Group Stock Performance
Shares of NYSEAMERICAN LGL traded down $0.15 during mid-day trading on Friday, hitting $7.40. The stock had a trading volume of 198 shares, compared to its average volume of 13,017. The firm has a market cap of $48.40 million, a PE ratio of 740.74 and a beta of 0.32. The company has a 50 day moving average of $6.95 and a two-hundred day moving average of $7.06. LGL Group has a twelve month low of $5.45 and a twelve month high of $7.57.
About LGL Group
LGL Group Inc is a United States–based company specializing in the development and commercialization of digital pathology and molecular imaging systems for research and clinical laboratories. The company’s core focus lies in enabling high-resolution visualization and quantitative analysis of tissue samples, helping scientists and pathologists accelerate biomarker discovery and diagnostic workflows. LGL Group’s platform combines advanced optics, automated slide scanning and image analysis software to deliver end-to-end solutions tailored to oncology, immunology and neuroscience research.
The company’s flagship offerings include whole-slide scanners capable of rapid, high-throughput scanning at resolutions suited for detailed morphometric and fluorescence studies.
See Also
- Five stocks we like better than LGL Group
- CAVA Earnings: The Easiest Comp of the Year Meets a Tough Valuation
- Joint Operations: Curaleaf Makes a Play for Aurora Cannabis
- Cerebras Sells Off After Earnings: Is This a Market Disconnection?
- Is Lockheed Martin Gearing Up to Lead Defense Stocks?
Receive News & Ratings for LGL Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LGL Group and related companies with MarketBeat.com's FREE daily email newsletter.
